ResMed (RMD)
(Delayed Data from NYSE)
$197.04 USD
-11.30 (-5.42%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $197.20 +0.16 (0.08%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Brokerage Reports
ResMed Inc. [RMD]
Reports for Purchase
Showing records 521 - 531 ( 531 total )
Company: ResMed Inc.
Industry: Medical - Products
RMD Take a deep breath: ResMed undervalued, upgrading to STRONG BUY
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
RMD Leaving money on the table, ResMed meets on EPS, misses on revenue
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
STOCKS WITH EXCEPTIONAL APPRECIATION OPPORTUNITY ONCE THE OVERALL MARKET STABILIZES
Provider: FELTL & COMPANY
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Survey data and currency movements suggest modest Q4 upside
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
UnitedHealthcare: Go home, use APAP - New coverage policy positive for ResMed
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
BiancaMed acquisition smart move, despite near-term dilution
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Acquires BiancaMed and new AASM sleep testing legislative effort.
Provider: FELTL & COMPANY
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Wake Up - skip the snooze button with a STRONG BUY, $40.40 PT
Provider: FELTL & COMPANY
Analyst: HAYNOR B